Moderna
MRNA
#1403
Rank
ยฃ11.80 B
Marketcap
ยฃ30.21
Share price
2.47%
Change (1 day)
7.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: ยฃ11.80 Billion

As of January 2026 Moderna has a market cap of ยฃ11.80 Billion. This makes Moderna the world's 1403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ11.80 B30.42%
2025ยฃ9.05 B-26.44%
2024ยฃ12.30 B-58.65%
2023ยฃ29.76 B-47.82%
2022ยฃ57.03 B-25.23%
2021ยฃ76.28 B151.54%
2020ยฃ30.32 B504.16%
2019ยฃ5.01 B26.92%
2018ยฃ3.95 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Moderna was reported to be:

ยฃ11.80 Billion
by Nasdaq info icon info icon
ยฃ11.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
ยฃ0.42 B-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ206.45 B 1,648.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.62 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ36.08 B 205.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ208.81 B 1,668.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
ยฃ6.84 B-42.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ392.05 B 3,220.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.21 B-81.22%๐Ÿ‡บ๐Ÿ‡ธ USA